[go: up one dir, main page]

MX2007006368A - Metodos de preparacion de aripiprazol anhidro forma ii. - Google Patents

Metodos de preparacion de aripiprazol anhidro forma ii.

Info

Publication number
MX2007006368A
MX2007006368A MX2007006368A MX2007006368A MX2007006368A MX 2007006368 A MX2007006368 A MX 2007006368A MX 2007006368 A MX2007006368 A MX 2007006368A MX 2007006368 A MX2007006368 A MX 2007006368A MX 2007006368 A MX2007006368 A MX 2007006368A
Authority
MX
Mexico
Prior art keywords
methods
anhydrous aripiprazole
preparing anhydrous
aripiprazole form
preparing
Prior art date
Application number
MX2007006368A
Other languages
English (en)
Inventor
Hagit Eisen-Nevo
Zhanna Pavlov
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of MX2007006368A publication Critical patent/MX2007006368A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

Esta invencion se relaciona con los metodos de preparacion de aripiprazol anhidro Forma II.
MX2007006368A 2005-09-29 2006-09-29 Metodos de preparacion de aripiprazol anhidro forma ii. MX2007006368A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72261605P 2005-09-29 2005-09-29
US72645605P 2005-10-12 2005-10-12
US73709205P 2005-11-15 2005-11-15
PCT/US2006/038279 WO2007041414A1 (en) 2005-09-29 2006-09-29 Methods of preparing anhydrous aripiprazole form ii

Publications (1)

Publication Number Publication Date
MX2007006368A true MX2007006368A (es) 2007-07-11

Family

ID=37670930

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007006368A MX2007006368A (es) 2005-09-29 2006-09-29 Metodos de preparacion de aripiprazol anhidro forma ii.

Country Status (7)

Country Link
EP (1) EP1934183A1 (es)
JP (1) JP2008521835A (es)
KR (1) KR20070088750A (es)
BR (1) BRPI0606163A2 (es)
IL (1) IL186278A0 (es)
MX (1) MX2007006368A (es)
WO (1) WO2007041414A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101340214B1 (ko) * 2011-03-31 2013-12-10 주식회사 대웅제약 무수 아리피프라졸 ⅱ형 결정의 제조방법
CN102850268B (zh) * 2011-06-27 2015-07-15 上海中西制药有限公司 阿立哌唑ⅰ型微晶、阿立哌唑固体制剂及制备方法
KR101372840B1 (ko) * 2012-08-02 2014-03-12 주식회사 에스텍파마 무수 아리피프라졸 결정의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2608788B2 (ja) 1988-10-31 1997-05-14 大塚製薬 株式会社 精神分裂病治療剤
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
JP5546717B2 (ja) 2003-12-16 2014-07-09 テバ ファーマシューティカル インダストリーズ リミティド アリピプラゾール結晶質形態を調製する方法

Also Published As

Publication number Publication date
BRPI0606163A2 (pt) 2009-05-26
JP2008521835A (ja) 2008-06-26
IL186278A0 (en) 2008-01-20
KR20070088750A (ko) 2007-08-29
WO2007041414A1 (en) 2007-04-12
EP1934183A1 (en) 2008-06-25

Similar Documents

Publication Publication Date Title
GB2432609A (en) Method of expansion
UA103794C2 (en) Liposome composition
IL172357A0 (en) Method for the production of substituted 3-aryl-butyl amine compounds
MX2010002836A (es) Bortezomib y proceso para la produccion del mismo.
IL188781A (en) A method for improving synchronization
ZA200711016B (en) Method for production of 1-alkyl-3-phenyluracils
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
MX2010001963A (es) Procedimiento para la preparacion de 4-aminobut-2-enolidos.
PL1767528T3 (pl) Sposób wytwarzania związku 5-hydroksy-4-tiometylopirazolowego
TNSN08244A1 (en) Process for the preparation of ferri-succinylcasein
TW200833649A (en) Method for the preparation of hydroxyadamantanamine
MX2010004592A (es) Metodo mejorado para producir diesteres.
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
MX2009010903A (es) Metodos para preparar compuestos basados en imidazol.
TW200740769A (en) Novel process
IN2012DN05081A (es)
TW200619205A (en) A method for preparing irbesartan and intermediates thereof
MX2009001150A (es) Aditivo que contiene titanio.
SI2093217T1 (sl) Postopek za pripravo oblike X aripiprazola
SG136920A1 (en) Process for producing methionine
MX2007006368A (es) Metodos de preparacion de aripiprazol anhidro forma ii.
TW200637832A (en) Process for preparing amorphous valsartan
MX2010001962A (es) Procedimiento para preparar 4-aminobut-2-enolidos.
SG142306A1 (en) Methods for neuroprotection
MY145842A (en) Method of producing triethanolamine

Legal Events

Date Code Title Description
FA Abandonment or withdrawal